Your browser doesn't support javascript.
loading
Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity.
J Hematol Oncol ; 6: 78, 2013 Oct 12.
Article in En | MEDLINE | ID: mdl-24283803

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Daunorubicin / Tumor Suppressor Protein p53 / Protein Kinase Inhibitors / Naphthyridines Limits: Humans Language: En Journal: J Hematol Oncol Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2013 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Daunorubicin / Tumor Suppressor Protein p53 / Protein Kinase Inhibitors / Naphthyridines Limits: Humans Language: En Journal: J Hematol Oncol Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2013 Type: Article